DOCSLIB.ORG

Patent Applications and Terms

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Patent Applications and Terms Mailer | October 2016 Patent Applications and Terms Today, there is a considerable variety of patent applications and it can often be a daunting task to recall and keep track of all of them. Patent Offices across the globe use terminologies that are foreign to many of us and more often than not, novice inventors and IP managers find it difficult to keep up with the web of patent applications, its kinds and their respective durations of enforceability. While the Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement) under Article 33, mandated a universal term of 20 years from the date of filing, there are countries which have granted extensions to patent terms and have also provided for patent term adjustments. Ergo, determining patent terms becomes an even more complicated assignment, in the presence of dense legalese. The duration of enforceability of a patent is one of its most important aspects because it plays a crucial role in Licensing and Litigation amongst many other things. In case of patent licensing, the value of each license depends on term of right to exclude and for litigation, patent term largely affects availability of injunctions, royalty amount and damages. Therefore, the determination of a life of a patent is necessary for critical legal and business decision making process. Though there is a standard term of 20 years agreed by countries, patent terms are affected by the types of applications that are filed in Patent Offices across the world. Types of Patent Applications Ordinary Application: Any application filed with a patent office without making any reference to any other existing applications under process with the Patent Office is referred as an Ordinary Application. Convention Application: When a patent applicant claims priority from a same or substantially similar patent application from one or more countries which are parties to convention(s), such application is called a Convention Application. To achieve a convention status, a patent applicant must file the application within 12 months from the date of first application made in a convention country. Provisional Application: Due to widespread competition, it becomes critically important to file a patent application as soon as possible. To secure the ‘priority date’, patent applicants can file non-final applications which adequately describe their invention. Such an application is called a provisional application. This then has to be followed by a Complete Specification within a period of twelve months from the date of filing of first application. PCT-International Phase Application: The Patent Cooperation Treaty (PCT) provides a unified procedure for filing patent applications and seeking patent protection in up to 150 member countries. The date of filing of the international application is recognized as the priority date internationally in all designated countries. PCT-National Phase Application: Once a patent applicant files the PCT International Phase Application, the patent applicant can file the patent application in all designated states separately within the time limit of 31 months (in most countries) from international filing date or the priority date (whichever is earlier). Divisional Application: When a patent applicant discovers on his own or through a patent office’s direction that the claims relates to more than one inventive concept, the applicant may divide the application and file it as two or more applications at the Patent office. This application, divided from a parent application, is known as a Divisional Application. The Priority date of a divisional application is same as the parent patent application. www.clairvolex.com Mailer | October 2016 Continuation Application: This is a patent application that follows, and claims priority to, an earlier-filed patent application. The earlier-filed application is non-provisional and an applicant can pursue additional claims to the invention which has already been disclosed. Continuation-In-Part (CIP) Applications: Such applications refer to substantially same specification as compared to the parent application filed by the applicant but this has additional subject matter which is not disclosed in the parent application. The claims which pertain to the disclosures of the parent application have a priority date of the parent application and the new claims will not share the same priority. The new claims are generally awarded priority date on which such claims are filed. Patent of Addition: When an applicant files an application for any improvement or modification of a previous disclosure/invention in a complete specification which has been already applied for or has been granted a patent, such an application is referred to as Patent of Addition. Reissue Application: When an unexpired patent is found to be defective for any reason and the patent is deemed wholly or partly inoperative or invalid, the patent applicant can surrender the defective patent and seek for a reissue patent which is defect free. Utility Patent Application: these are also referred to as ‘petty patents’ or ‘innovation patents’ in many jurisdictions. Such applications are similar to Ordinary Patent Applications but are granted patent rights for incremental innovation for a short period time (6-12 years). Determining Base Patent Terms – A brief overview: Countries Patent Term in the Patent Term in Patent Term in Patent Term in Patent Term in Patent Term in United States of India Europe Australia Canada Japan Kinds of Applications America Ordinary Application 20 years from the 20 years from the date 20 years as from the 20 years from the date 20 years from the date 20 years from the filing date of filing which is of filing. date of filing. But of filing. Patent term of filing. date. Extension of subject to patent term member countries are extendable only in case patent term by up to adjustments, terminal free to extend term of of pharmaceuticals. 5 years is available for disclaimers* and patent Patent. pharmaceuticals and term extensions. agricultural chemicals. Convention Application 20 years from earliest 20 years from earliest 20 years from earliest 20 years from earliest 20 years from earliest 20 years from earliest date of filing in the US. date of filing in date of filing in date of filing in date of filing in date of filing in Convention country. Convention country. Convention country. Convention country. Convention country. Provisional Application 20 years from the 20 years from the 20 years from the date 20 years from the date 20 years from the date No formal system date of filing of final earliest filing. Can of filing the complete of complete disclosure of filing of complete for filing provisional Non-provisional patent be post-dated for a application. of the invention. application. application. But application. period of 12 months applications can be until filing of complete filed provisionally and specification. the term of a patent is calculated from the date of filing of complete application. PCT National Phase 20 years from the date of international filing. Nationalization of a PCT International Phase application deadline is 30 or 31 months in most countries. Application Divisional Application 20 years from the date of filing of parent application. Continuation 20 years from the N/A Application date of filing of the application. Continuation in Part 20 years from the date N/A Application of original application. Added claims have varying priority. Utility Model 10 years from the date N/A 6 years from the date Innovation Patents have N/A 10 years from the date Applications of filing. of filing. a term of 8 years from of filing. the date of filing. * Terminal Disclaimers: In situations where a patent applicant has two patent applications where one claim is an obvious variation of the second patent/application and one application is citable as other’s prior art, a terminal disclosure application can be filed. This written statement by the applicant helps in fighting the double-patenting objection raised by the patent office and states that the applicant has disclaimed the period of the second issued patent that would extend beyond the expiration of the first patent. The second patent usually expires at the same time as the first in most cases, the extra portion having been disclaimed. www.clairvolex.com Mailer | October 2016 Patent Term Extensions and Adjustments United States of America: The US introduced a system called Patent Term Adjustments which was applicable in cases of unnecessary delays by the Patent Office during prosecution. In case of unnecessary delays by the patent applicant, the application is deemed abandoned/withdrawn. The applicant can fight it only under exceptional circumstances. • The delays by the patent office are categorized into A, B and C delays. A delays occur when patent office isn’t responding promptly within prescribed deadlines. A delays are included in the patent term adjustment determination and is mailed as a part of Issue Notification Letter. B delays are the failure to issue patents within three years (the three year calculation is paused in cases of declaration of interferences, secrecy order and notice of appeal) from the date of filing or in case of PCT Applications, three years from the date of national phase and the C delay includes any other reasons such as interference proceedings, secrecy orders, and successful appellate reviews for the calculation of patent term adjustments. Patentee is entitled to the addition of ‘A Delays’ and ‘B Delays’ to the extent that they do not overlap. • In case of ‘overlap’ of delays- A and B delays overlap only if they occur on the same day (which can only occur after the application has been pending for at least 3 years). Europe introduced a system of patent term extension through Supplementary Protection Certificates (SPCs) for products such as the Active Pharmaceutical Ingredients (APIs) which undergo assessment of safety and efficacy studies before market authorization.
Load more

Recommended publications
  • Basic Understanding of Intellectual Property
    BASIC UNDERSTANDING OF INTELLECTUAL PROPERTY Jacob N. (Jesse) Erlich, Partner, Burns & Levinson LLP Kathy Chapman, Assistant Counsel IP, U.S. Naval Research Laboratory BACKROUND A company or individual entering the world of business should maintain ownership of its innovative developments. These innovative developments generally take the form of intellectual property, which is broadly defined as protectable developments of the mind. A more formal definition of intellectual property is an intangible or proprietary asset such as a patent, copyright, trademark, or trade secret. To better understand the various aspects of intellectual property protection, it is best to first understand that most intellectual property, particularly inventions, begins as a trade secret. Although patents may be the most common and well-known form of intellectual property, at its outset all forms of intellectual property begin as a trade secret. A trade secret is used to protect important business information that a business or an individual does not want to disclose to the public. In other words, to rely on trade secret protection, one must ensure that such trade secrets remain confidential. As a business develops, it becomes increasingly difficult to keep such information confidential; as such, the chances are that this information will become released to the public and protection will be lost. Therefore, it is important to understand various other types of intellectual property protection such as patents, trademarks, and copyrights. TRADE SECRETS The use of trade secrets to protect one's ideas is extremely important and can be considered an essential part of a business. However, to use trade secrets as a form of intellectual property protection, trade secrets must be kept confidential.
    [Show full text]
  • Effects of Supplementary Protection Mechanisms for Pharmaceutical Products
    Final report, May 2018 Effects of supplementary protection mechanisms for pharmaceutical products www.technopolis-group.com Effects of supplementary protection mechanisms for pharmaceutical products technopolis |group| May 2018 Thyra de Jongh* Alfred Radauer Sven Bostyn Joost Poort * Corresponding author. [email protected] About the authors Thyra de Jongh PhD, is a Senior Consultant Health & Life Sciences at Technopolis Group in Amsterdam. She specialises in analysis of health systems and policies, and research and innovation in the health and life sciences. She has a particular interest in pharmaceutical innovation and access to medicine. (thyra.dejongh@technopolis- group.com) Alfred Radauer, is Senior Consultant at Technopolis Group in Vienna and leads the Intellectual Property & Standards (IPS) group within Technopolis. His and the IPS group work elaborate on the interfaces between legal, technological and economic issues of IP and standards in innovation policy as well as the interaction of IP with regulation and other policy areas. ([email protected]) Sven Bostyn Lic.Jur, LL.M, PhD, is a senior lecturer in Intellectual Property Law at the University of Liverpool Law School. He is also an assistant professor at the Institute for Information Law, University of Amsterdam. He is one of the leading experts in Europe in patent law and related subjects in the areas of life sciences and pharmaceutical inventions, and has more than sixty single-authored publications. ([email protected]) Joost Poort PhD, is an associate professor in economics at the Institute for Information law, University of Amsterdam. He brings an economic perspective to various multidisciplinary research projects, with particular interest in intellectual property.
    [Show full text]
  • US Patent Basics
    US Patent Basics *A free e-copy of this book is available by request to [email protected]. US Patent Basics By Tamsen Valoir, PhD. Tamsen is a partner in the Houston office of Boulware & Valoir. She has a JD and LLM in Intellectual Property, a doctorate in molecular biology from Rice University, and her practice is primarily in intellectual property in the area of life sciences. [email protected]. 7th Edition, © 2012. Table of Contents 1. US PATENT BASICS ................................................................... 2 2. BEST MODE, OATH, CANDOR .................................................. 15 3. INVENTORSHIP ....................................................................... 18 4. PATENT REFORM 2011 ........................................................... 21 5. COST CONTROL ..................................................................... 29 6. PATENT STRATEGY ................................................................. 32 7. INTERNATIONAL PROTECTION ................................................ 38 8. RECEIPT OF A US PATENT ....................................................... 41 9. PATENT ENFORCEMENT .......................................................... 44 10. OTHER TYPES OF PROTECTION .............................................. 46 11. FDA BASICS .......................................................................... 49 12. TEN ISSUES FOR THE START-UP ............................................ 54 13. PATENT STATUTES ...............................................................
    [Show full text]
  • “The Origin of Specis” (Patent Specifications) BASIC FACTS (A.K.A
    The Origin of Specis (or, nearly everything you wanted to know about patents, but couldn’t be bothered asking) 22.Sep.2021 © Tony McStea 1992-2021 22.Sep.2021 About the Author… (with apologies to Gilbert and Sullivan) When I was a lad, I served a term As patent tech. assistant in a big paint firm I wrote applications and I argued and tried Patent offices to show that grant was justified And this sort of thing so suited me That now I’m patent attorney in industry. Acknowledgement My grateful thanks to all of you out there who helped me with this revised version by offering comments, corrections, criticisms, suggestions and advice, some of which I ignored, which is why the booklet still exists. The responsibility for any errors (not to mention the mediocre drawings and terrible jokes (or is it mediocre jokes and terrible drawings?)) is entirely mine. The responsibility for any views or opinions expressed herein is also entirely mine. N.B. Most costs mentioned herein were correct (more or less) at June, 2015, but, because of the tendency of official fees to fluctuation (and exchange rates to go up and down like yo-yos), and the consequent work of constantly adjusting them, they have been left as they are and are there to be general guides only. 22.Sep.2021 Note: changes to US Law On 16 March 2013 (thus missing by one day the Blessing of St. Patrick on the entire enterprise), the Leahy-Smith “America invents” Act (AIA), the most significant change to US patent law in half a century, came fully into effect.
    [Show full text]
  • U.S. Patent and Trademark Office
    U.S. Patent and Trademark Office Fiscal Year 2022 Congressional Justification May 2021 This Page is Intentionally Left Blank DEPARTMENT OF COMMERCE UNITED STATES PATENT AND TRADEMARK OFFICE Budget Estimates, Fiscal Year 2022 Congressional Justification Table of Contents Exhibit Number Exhibit Page Number 2 Organization Chart USPTO - 4 3 Executive Summary USPTO - 5 Patent and Trademark Businesses: Five-Year Horizon 3T Transfer Change Detail by Object Class USPTO - 19 4A Program Increases / Decreases / Terminations USPTO - 20 4T Transfer Summary Table USPTO - 22 5 Summary of Resource Requirements: Direct Obligations USPTO - 23 7 Summary of Financing USPTO - 25 8 Adjustments-to-Base USPTO - 26 Patent Program 10 Program and Performance: Direct Obligations USPTO - 28 12 Justification of Program and Performance (by Subactivity) USPTO - 29 13 Program Change for 2022 USPTO - 34 14 Program Change Personnel Detail USPTO - 35 15 Program Change Detail by Object Class USPTO - 41 Trademark Program 10 Program and Performance: Direct Obligations USPTO - 44 12 Justification of Program and Performance (by Subactivity) USPTO - 45 13 Program Change for 2022 USPTO - 50 14 Program Change Personnel Detail USPTO - 55 15 Program Change Detail by Object Class USPTO - 57 Intellectual Property Policy, Enforcement and Protection Program 10 Program and Performance: Direct Obligations USPTO - 60 12 Justification of Program and Performance (by Subactivity) USPTO - 61 Exhibit Number Exhibit Page Number 13 Program Change for 2022 USPTO - 65 14 Program Change Personnel
    [Show full text]
  • Table of Patent Fees - Current, Final Rule and Unit Cost
    Table of Patent Fees - Current, Final Rule and Unit Cost Current Fees Final Rule Fees Increase/(Decrease) Percentage Change Unit Cost Large Small Micro Large Small Micro Large Small Micro Large Small Micro Change in Large Fee Code 37 CFR Description Entity Entity Entity Entity Entity Entity Entity Entity Entity Entity Entity Entity FY 2013 FY 2014 FY 2015 Entity Fees is Fee Fee Fee Fee Fee Fee Fee Fee Fee Fee Fee Fee >10% AND >$20 Patent Application Filing Fees Basic Filing fee - Utility (paper filing also requires non-electronic 1011/2011/3011 1.16(a) filing fee under 1.16(t)) $280 $140 $70 $300 $150 $75 $20 $10 $5 7% 7% 7% $262 $257 $277 4011 1.16(a) Basic filing fee - Utility (electronic filing for small entities) n/a $70 n/a n/a $75 n/a n/a $5 n/a n/a 7% n/a n/a $257 n/a 1012/2012/3012 1.16(b) Basic Filing Fee - Design $180 $90 $45 $200 $100 $50 $20 $10 $5 11% 11% 11% $262 $257 $277 1017/2017/3017 1.16(b) Basic Filing Fee - Design (CPA) $180 $90 $45 $200 $100 $50 $20 $10 $5 11% 11% 11% $707 $772 $884 1013/2013/3013 1.16(c) Basic Filing Fee - Plant $180 $90 $45 $200 $100 $50 $20 $10 $5 11% 11% 11% $262 $257 $277 1005/2005/3005 1.16(d) Provisional Application Filing Fee $260 $130 $65 $280 $140 $70 $20 $10 $5 8% 8% 8% $152 $144 $154 1014/2014/3014 1.16(e) Basic Filing Fee - Reissue $280 $140 $70 $300 $150 $75 $20 $10 $5 7% 7% 7% $260 $256 $277 1019/2019/3019 1.16(e) Basic Filing Fee - Reissue (CPA) $280 $140 $70 $300 $150 $75 $20 $10 $5 7% 7% 7% $707 $772 $884 Surcharge - Late Filing Fee, Search Fee, Examination Fee, Inventor's Oath
    [Show full text]
  • Comparative Research on the Patent Systems of Japan, the United States and Europe
    Comparative Research on the Patent Systems of Japan, the United States and Europe Japan Patent Office Asia - Pacific Industrial Property Center, Japan Institute for Promoting Invention and Innovation ©2017 Collaborator: Mr. Tetsuo SHIBA Partner, Patent Attorney SHOBAYASHI International Patent & Trademark Office Comparative Research on the Patent Systems of Japan, the United States and Europe March 2017 Patent systems have faced an era of significant change over the last 40 years. The enforcement of the European Patent Convention in 1977 and the Patent Cooperation Treaty in 1978 (hereinafter referred to respectively as the “EPC” and “PCT”) opened the path to globalization in the field of intellectual property rights. In 1982, the system of Court of Appeals for the Federal Circuit (CAFC) was established in the U.S.—a country where common laws are considered the basis of trials—and this dramatically contributed to the pro-patent policy. One of the background factors to this situation is that of trade issues, as is seen in the enforcement of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) in 1995. In line with these trends, important revisions of patent acts were executed in the three regions of Japan, the U.S. and Europe. These include the revision of many provisions of the Patent Act in Japan, the enforcement of the revised EPC (EPC 2000) in Europe, and the transferal of the patent system in the U.S. from the first-to-invent to the first-to-file system, along with the establishment of the Leahy-Smith America Invents Act (AIA) in 2011 (effective dates vary among the revised provisions).
    [Show full text]
  • ST.27 Page: 3.27.Vi.1
    HANDBOOK ON INDUSTRIAL PROPERTY INFORMATION AND DOCUMENTATION Ref.: Standards - ST.27 page: 3.27.vi.1 ANNEX VI GUIDANCE DOCUMENT Adopted Revision approved by the Committee on WIPO Standards (CWS) at its sixth seventh session on October 19, 2018July 5, 2019 TABLE OF CONTENTS INTRODUCTION ................................................................................................................................................................ 2 STRUCTURE OF EXAMPLES ............................................................................................................................................ 2 EXAMPLES ........................................................................................................................................................................ 3 Category A: Application filing.......................................................................................................................................... 3 Category B: Application discontinuation ......................................................................................................................... 6 Category C: Application revival ...................................................................................................................................... 9 Category D: Search and examination ........................................................................................................................... 11 Category E: Pre-grant review requested .....................................................................................................................
    [Show full text]
  • OECD Studies on Environmental Innovation – Invention and Transfer of Environmental Technologies
    Invention and Transfer of Environmental Technologies © OECD 2011 ANNEX C Glossary of Relevant Patent and Related Terms Adoption: The point at which a technology is selected for use by an individual or an organisation. Applicant: The person or company that applies for the patent and intends to “work” the invention (i.e. to manufacture or license the technology). In most countries the inventor(s) does not necessarily have to be the applicant. Application (or filing) date: The patent application date is the date on which the patent office received the patent application. Application for a patent: To obtain a patent, an application must be filed with the authorised body (patent office, or application authority) with all the necessary documents and fees. The patent office will conduct an examination to decide whether to grant or reject the application. Assignee: The person(s) or corporate body to whom all or limited rights under a patent are legally transferred. Assignment of all or limited rights under a patent. Bibliometrics: Study of the quantitative data of the publication patterns of individual articles, journals, and books in order to analyze trends and make comparisons within a body of literature. Breadth (or scope): A measure of the extent of the invention covered by a single patent application. For example, one patent application to the EPO would generally include more claims than an application to the JPO. Citations: They comprise a list of references that are believed to be relevant prior art and which may have contributed to the “narrowing” of the original application. Citations may be made by the examiner or the applicant/inventor.
    [Show full text]
  • Basic Features to the Patent Law Treaty (PLT)
    November 2006 Basic Features to the Patent Law Treaty (PLT) Document prepared by the Secretariat page 2 CONTENTS Page Introduction ..............................................................................................................................3 Module 1: Filing Date Requirements......................................................................................4 The PLT sets up requirements for obtaining a filing date and procedures to avoid a loss of the filing date because of a failure to comply with other formality requirements. Module 2: Standardized Applications.....................................................................................6 The PLT establishes a single internationally standardized set of formal requirements for national and regional applications, based on the requirements for international applications under the PCT. Module 3: Standardized Forms ...............................................................................................8 The PLT establishes standardized Forms which shall be accepted by all Offices. Module 4: Simplified Procedures Before the Office.............................................................10 The PLT simplifies a number of procedures before Offices, contributing to a reduction of costs for applicants as well as Offices. Module 5: Avoiding Loss of Rights......................................................................................13 The PLT avoids unintentional loss of substantive rights and reinstatement of rights as a result of failure to comply
    [Show full text]
  • MPEP Chapter 2700 Patent Terms and Extensions
    Chapter 2700 Patent Terms and Extensions 2763 Limitation of Third Party Participation 2701 Patent Term 2764 Express Withdrawal of Application for 2710 Term Extensions or Adjustments Extension of Patent Term for Delays Within the USPTO Under 35 U.S.C. 154 2701 Patent Term [R-2] 2720 Applications Filed Between June 8, 1995, and May 28, 2000 35 U.S.C. 154. Contents and term of patent; provisional 2730 Applications Filed On or After rights. May 29, 2000; Grounds for Adjustment (a) IN GENERAL.— >2731 Period of Adjustment ***** 2732 Reduction of Period of Adjustment of Patent (2) TERM.—Subject to the payment of fees under this Term title, such grant shall be for a term beginning on the date on which 2733 Determination of Patent Term Adjustment the patent issues and ending 20 years from the date on which the 2734 Application for Patent Term Adjustment; Due application for the patent was filed in the United States or, if the Care Showing application contains a specific reference to an earlier filed applica 2735 Request for Reconsideration of Patent Term tion or applications under section 120, 121, or 365(c) of this title, from the date on which the earliest such application was filed. Adjustment Determination (3) PRIORITY.—Priority under section 119, 365(a), or 2736 Third Party Papers< 365(b) of this title shall not be taken into account in determining 2750 Patent Term Extension for Delays at other the term of a patent. Agencies Under 35 U.S.C. 156 ***** 2751 Eligibility Requirements 2752 Patent Term Extension Applicant (c) CONTINUATION.— 2753 Application Contents (1) DETERMINATION.—The term of a patent that is in 2754 Filing Date force on or that results from an application filed before the date that is 6 months after the date of the enactment of the Uruguay 2754.01 Deadline for Filing an Application Under Round Agreements Act shall be the greater of the 20-year term as 35 U.S.C.
    [Show full text]
  • Title Emergence of Essential Patents in Technical Standards
    Emergence of Essential Patents in Technical Standards: Implications of the Continuation and Title Divisional Application Systems and the Written Description Requirement Author(s) Omachi, Masayoshi Citation Issue Date 2004-12-13 Type Technical Report Text Version publisher URL http://hdl.handle.net/10086/15993 Right Hitotsubashi University Repository Institute Hitotsubashi of Inno U niversity vation R e search Institute of Innovation Research Hitotsubashi University Tokyo, Japan http://www.iir.hit-u.ac.jp Emergence of Essential Patents in Technical Standards: Implications of the Continuation and Divisional Application Systems and the Written Description Requirement1 Masayoshi Omachi2 Conference on IT Innovation Sano-Shoin Hall, Hitotsubashi University, Tokyo December 13, 2004 Abstract The present paper looks into the intersection between technical standard development activities and patenting activities from the perspective of patent prosecution. Specifically, attention is paid to the tendency that the obtainment of patents related to technical standards is often done through the utilization of the systems allowing patent applicants to file new applications (collectively called continuing applications under the US patent system) enjoying the benefit of the filing dates of earlier-filed patent applications. After presenting some empirical evidence to show the tendency (in other words, the relevance of the continuing application system to patenting technical standards), this paper focuses upon the written description requirement as an important factor affecting the patentability of such continuing applications. In this paper, I make concrete proposals for the enhancement of the capacity of the written description requirement to suppress the abusive use of the continuing application system to cover technical standards as well as competitors’ products and processes, without prejudice to innovative inventors’ opportunities to mine their original disclosure in patent specifications for the exclusive rights they deserve.
    [Show full text]